
TJX · NYSE
The consensus is Buy, backed by 23 analysts, with a mean price target of $178. The supplied consensus does not provide low or high targets, so the target cluster and total spread cannot be measured; the most and least bullish analysts are likewise not identifiable. UBS was the clearest named voice in the week's coverage, expecting in-line second-quarter EPS and a full-year guidance increase, but no explicit price-target revision was supplied. The substantive disagreement is therefore between confidence in TJX's steady earnings, trading-down benefits and possible guidance increase, and concern that the shares are already expensive. No attributable rating changes or target revisions over the week are stated.